{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:31:51Z","timestamp":1790058711042,"version":"4.0.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1093\/carcin\/bgt008","type":"journal-article","created":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T20:14:37Z","timestamp":1358280877000},"page":"1012-1017","source":"Crossref","is-referenced-by-count":29,"title":["Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk"],"prefix":"10.1093","volume":"34","author":[{"given":"Jennifer R.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.B.","family":"Gramling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dangxiao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duoduo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abul K.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvina","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mirshams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale H.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph W.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Gullane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Irish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Reisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,1,15]]},"reference":[{"key":"key\n\t\t\t\t20170520225553_CIT0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin"},{"key":"key\n\t\t\t\t20170520225553_CIT0002","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","article-title":"Head and neck cancer","volume":"371","author":"Argiris","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170520225553_CIT0003","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1368-8375(00)00021-X","article-title":"Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations","volume":"36","author":"Scully","year":"2000","journal-title":"Oral Oncol"},{"key":"key\n\t\t\t\t20170520225553_CIT0004","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/1097-0347(200103)23:3<238::AID-HED1025>3.0.CO;2-H","article-title":"Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease","volume":"23","author":"Gollin","year":"2001","journal-title":"Head Neck"},{"key":"key\n\t\t\t\t20170520225553_CIT0005","first-page":"1156","article-title":"Frequent loss of chromosome 9p21-22 early in head and neck cancer progression","volume":"54","author":"van der Riet","year":"1994","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170520225553_CIT0006","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/07357900802563010","article-title":"Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma","volume":"27","author":"Gunduz","year":"2009","journal-title":"Cancer Invest"},{"key":"key\n\t\t\t\t20170520225553_CIT0007","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170520225553_CIT0008","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1158\/1078-0432.CCR-03-0489","article-title":"Chromatin remodeling factors and BRM\/BRG1 expression as prognostic indicators in non-small cell lung cancer","volume":"10","author":"Fukuoka","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20170520225553_CIT0009","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2009.4","article-title":"The SWI\/SNF complex and cancer","volume":"28","author":"Reisman","year":"2009","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520225553_CIT0010","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1038\/sj.onc.1210514","article-title":"The reversible epigenetic silencing of BRM: implications for clinical targeted therapy","volume":"26","author":"Glaros","year":"2007","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520225553_CIT0011","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1038\/onc.2011.80","article-title":"Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy","volume":"30","author":"Gramling","year":"2011","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520225553_CIT0012","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1158\/0008-5472.CAN-08-1794","article-title":"The SWI\/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer","volume":"68","author":"Shen","year":"2008","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170520225553_CIT0013","doi-asserted-by":"crossref","first-page":"10727","DOI":"10.1158\/0008-5472.CAN-07-2601","article-title":"Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state","volume":"67","author":"Yamamichi","year":"2007","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170520225553_CIT0014","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1038\/onc.2011.81","article-title":"Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk","volume":"30","author":"Liu","year":"2011","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520225553_CIT0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.lungcan.2009.03.030","article-title":"Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience","volume":"67","author":"Menezes","year":"2010","journal-title":"Lung Cancer"},{"key":"key\n\t\t\t\t20170520225553_CIT0016","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.radonc.2010.03.015","article-title":"Point-of-care outcome assessment in the cancer clinic: audit of data quality","volume":"95","author":"Wong","year":"2010","journal-title":"Radiother. Oncol"},{"key":"key\n\t\t\t\t20170520225553_CIT0017","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1038\/sj.onc.1208716","article-title":"The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential","volume":"24","author":"Yamamichi","year":"2005","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520225553_CIT0018","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2133.2011.10267.x","article-title":"BRM and BRG1 subunits of the SWI\/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours","volume":"164","author":"Bock","year":"2011","journal-title":"Br. J. Dermatol"},{"key":"key\n\t\t\t\t20170520225553_CIT0019","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1128\/MCB.16.4.1576","article-title":"Functional interactions between the hBRM\/hBRG1 transcriptional activators and the pRB family of proteins","volume":"16","author":"Strober","year":"1996","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20170520225553_CIT0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/107327480200900502","article-title":"Molecular genetics of head and neck cancer","volume":"9","author":"Gleich","year":"2002","journal-title":"Cancer Control"},{"key":"key\n\t\t\t\t20170520225553_CIT0021","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/jcp.22533","article-title":"BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest","volume":"226","author":"Bartlett","year":"2011","journal-title":"J. Cell. Physiol"},{"key":"key\n\t\t\t\t20170520225553_CIT0022","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1093\/emboj\/17.23.6979","article-title":"Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha)","volume":"17","author":"Reyes","year":"1998","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20170520225553_CIT0023","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-1702(02)00190-9","article-title":"Human papillomavirus immortalization and transformation functions","volume":"89","author":"Munger","year":"2002","journal-title":"Virus Res"},{"key":"key\n\t\t\t\t20170520225553_CIT0024","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20170520225553_CIT0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Gillison","year":"2008","journal-title":"J. Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170520225553_CIT0026","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/MCB.16.1.437","article-title":"Quantitative discrimination of MEF2 sites","volume":"16","author":"Fickett","year":"1996","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20170520225553_CIT0027","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/MCB.00882-06","article-title":"Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2","volume":"27","author":"Gregoire","year":"2007","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20170520225553_CIT0028","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone-deacetylase inhibitors: novel drugs for the treatment of cancer","volume":"1","author":"Johnstone","year":"2002","journal-title":"Nat. Rev. Drug Discov"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/34\/5\/1012\/17292907\/bgt008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T05:57:13Z","timestamp":1562565433000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgt008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,15]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,1,15]]},"published-print":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgt008","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,15]]}}}